Skip to main content
. 2018 Jul 22;2018:7464320. doi: 10.1155/2018/7464320

Table 3.

Demographic and clinical findings of subjects with and without macrovascular disease.

Variable No macrovascular disease (n = 49) Macrovascular disease (n = 72) p value
Age (years) 66 (62–69) 61 (54.25–67) 0.001
Male : female (n (%)) 34 (69.4) : 15 (30.6) 55 (76.4) : 17 (23.6) 0.41
Diabetes duration (years) 3.5 (2–5) 3 (2–4) 0.23
Smoking (current/ex/nonsmokers) (n (%)) 4 (8.1)/19 (38.8)/26 (53.1) 18 (25.0)/22 (30.6)/32 (44.4) 0.06
Hypertension (n (%)) 29 (59.18) 51 (70.83) 0.24
Hyperlipidaemia (n (%)) 36 (73.47) 51 (70.83) 0.84
CKD (n (%)) 2 (4.08) 7 (9.72) 0.31
Metformin (n (%)) 44 (89.80) 65 (90.28) 1.00
Sulphonylurea (n (%)) 14 (28.57) 50 (69.44) 0.84
Gliptins (n (%)) 4 (8.16) 2 (2.77) 0.22
Insulin (n (%)) 1 (2.04) 5 (6.94) 0.40
ACEI/ARB (n (%)) 29 (59.18) 48 (66.67) 0.44
β-blocker (n (%)) 7 (14.29) 15 (20.83) 0.47
CCB (n (%)) 11 (22.45) 12 (16.67) 0.48
Diuretic (n (%)) 14 (28.57) 19 (26.39) 0.84
Aspirin (n (%)) 9 (18.36) 29 (40.28) 0.02
Statin (n (%)) 29 (59.18) 52 (72.22) 0.17
Fibrate (n (%)) 6 (12.24) 1 (1.39) 0.02
Allopurinol (n (%)) 2 (4.08) 3 (4.17) 1.00
BMI (kg/m2) 31.22 (27.67–33.97) 31.31 (27.9–35.19) 0.35
BSA (m2) 1.83 ± 0.20 1.93 ± 0.21 0.007
Waist index 1.17 ± 0.15 1.20 ± 0.13 0.22
Pulse rate (bpm) 65 (61–80.25) 71 (62–78) 0.84
Mean SBP (mmHg) 146 ± 18.28 142.96 ± 17.54 0.36
Mean DBP (mmHg) 85.66 ± 7.34 83.88 ± 9.58 0.25
Pulse pressure (mmHg) 62.18 ± 15.6 61.07 ± 12.22 0.68
MAP (mmHg) 106 (97.5–112.5) 90.75 (107.5–113) 0.77

Values are expressed as number (%) of patients, mean ± SD, or median (IQR). ACEI: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; BMI: body mass index; BSA: body surface area; CCB: calcium channel blocker; CKD: chronic kidney disease; CVD: cardiovascular disease; DM: diabetes mellitus; DBP: diastolic blood pressure; MAP: mean arterial pressure; SBP: systolic blood pressure.